Literature DB >> 20849135

Molecular dynamics and physical stability of amorphous anti-inflammatory drug: celecoxib.

K Grzybowska1, M Paluch, A Grzybowski, Z Wojnarowska, L Hawelek, K Kolodziejczyk, K L Ngai.   

Abstract

By using dielectric spectroscopy we analyzed the relation between molecular mobility and tendency of the amorphous celecoxib to recrystallize. We found that celecoxib is kinetically a fragile glassformer, contrary to the conclusion reached by others from thermodynamic fragility. The possible correlation of the large tendency of celecoxib to crystallize with various molecular motions have been investigated. Our study shows that the structural relaxation seems to be responsible for devitrification of celecoxib if stored at room temperature ∼293 K. Notwithstanding, the crystallization can be considered to ultimately be affected by the β-process (JG-relaxation) because it is the precursor of the structural α-relaxation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849135     DOI: 10.1021/jp1040212

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  12 in total

1.  Effects of cooling rate on structural relaxation in amorphous drugs: elastically collective nonlinear langevin equation theory and machine learning study.

Authors:  Anh D Phan; Katsunori Wakabayashi; Marian Paluch; Vu D Lam
Journal:  RSC Adv       Date:  2019-12-04       Impact factor: 4.036

2.  Molecular dynamics and the translational-rotational coupling of an ionically conducting glass-former: amlodipine besylate.

Authors:  Safna Hussan K P; Mohamed Shahin Thayyil; S K Deshpande; Jinitha T V; Manoj K; K L Ngai
Journal:  RSC Adv       Date:  2018-06-06       Impact factor: 4.036

3.  Vapor-Deposited Thin Films: Studying Crystallization and α-relaxation Dynamics of the Molecular Drug Celecoxib.

Authors:  Aparna Beena Unni; Roksana Winkler; Daniel Marques Duarte; Wenkang Tu; Katarzyna Chat; Karolina Adrjanowicz
Journal:  J Phys Chem B       Date:  2022-05-17       Impact factor: 3.466

4.  Studies on the Vitrified and Cryomilled Bosentan.

Authors:  Aldona Minecka; Krzysztof Chmiel; Karolina Jurkiewicz; Barbara Hachuła; Rafał Łunio; Daniel Żakowiecki; Kinga Hyla; Bartłomiej Milanowski; Kajetan Koperwas; Kamil Kamiński; Marian Paluch; Ewa Kamińska
Journal:  Mol Pharm       Date:  2021-12-01       Impact factor: 4.939

5.  Exploring molecular reorientations in amorphous and recrystallized felodipine at the microscopic level.

Authors:  A Pajzderska; J Jenczyk; J P Embs; J Wąsicki
Journal:  RSC Adv       Date:  2020-10-08       Impact factor: 4.036

6.  Exploring the molecular reorientations in amorphous rosuvastatin calcium.

Authors:  N M Belozerova; P Bilski; M Jarek; J Jenczyk; S E Kichanov; D P Kozlenko; J Mielcarek; A Pajzderska; J Wąsicki
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 3.361

7.  Synthesis of Celecoxib-Eutectic Mixture Particles via Supercritical CO2 Process and Celecoxib Immediate Release Tablet Formulation by Quality by Design Approach.

Authors:  Seung-Hyeon Hong; Linh Dinh; Sharif Md Abuzar; Eun Seok Lee; Sung-Joo Hwang
Journal:  Pharmaceutics       Date:  2022-07-26       Impact factor: 6.525

8.  Crystallization and phase changes in paracetamol from the amorphous solid to the liquid phase.

Authors:  Juraj Sibik; Michael J Sargent; Miriam Franklin; J Axel Zeitler
Journal:  Mol Pharm       Date:  2014-03-13       Impact factor: 4.939

9.  Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals-The Case of Simvastatin.

Authors:  Justyna Knapik-Kowalczuk; Daniel Kramarczyk; Krzysztof Chmiel; Jana Romanova; Kohsaku Kawakami; Marian Paluch
Journal:  Pharmaceutics       Date:  2020-04-22       Impact factor: 6.321

10.  Acoustic-like dynamics of amorphous drugs in the THz regime.

Authors:  E A A Pogna; C Rodríguez-Tinoco; M Krisch; J Rodríguez-Viejo; T Scopigno
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.